Blog

Tiny stem cell companies close in on goals – NEWS.com.au

Tiny stem cell companies close in on goals
NEWS.com.au
Both have overcome major hurdles to manufacturing stem cell treatments on a large scale that are off-the-shelf products derived from healthy donor bone marrow and do not face immune system rejection issues. Australia's Mesoblast, with a market value of

and more »

2017-12-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.